RIGEL PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2015
Total Assets: $131.7M
Liabilities Breakdown FY2015
Total Liabilities: $40.4M
Asset Breakdown
Total Assets: $131.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $43.5M | 33.0% |
| Accounts Receivable | $203.0K | 0.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.6M | 1.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $86.5M | 65.6% |
Liabilities Breakdown
Total Liabilities: $40.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.8M | 6.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $37.6M | 93.2% |